Ganel, Liron http://orcid.org/0000-0002-8762-622X
Chen, Lei
Christ, Ryan
Vangipurapu, Jagadish
Young, Erica
Das, Indraniel
Kanchi, Krishna
Larson, David
Regier, Allison
Abel, Haley
Kang, Chul Joo
Scott, Alexandra
Havulinna, Aki
Chiang, Charleston W. K.
Service, Susan
Freimer, Nelson
Palotie, Aarno
Ripatti, Samuli
Kuusisto, Johanna
Boehnke, Michael
Laakso, Markku
Locke, Adam
Stitziel, Nathan O.
Hall, Ira M.
Funding for this research was provided by:
National Human Genome Research Institute (UM1 HG008853, 5U54HG003079)
Sigrid Juséliuksen Säätiö
University of Helsinki HiLIFE
Academy of Finland (312062, 285380)
National Heart, Lung, and Blood Institute (T32HL007081)
National Center for Advancing Translational Sciences (UL1TR002345)
Article History
Received: 23 March 2021
Accepted: 26 May 2021
First Online: 7 June 2021
Declarations
:
: All participants in both the METSIM and FINRISK studies provided informed consent, and study protocols were approved by the Ethics Committees at participating institutions (National Public Health Institute of Finland, Hospital District of Helsinki and Uusimaa, and Hospital District of Northern Savo). All relevant ethics committees approved this study.
: Not applicable
: NOS has received grant funding from Regeneron Pharmaceuticals for unrelated work. The rest of the authors declare no competing interests.